Showing results (201-210 of 258) with videos related to
Sort By:
Pageof 26
Journal of Medicinal Chemistry|March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer TreatmentClaudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.Anti-Cancer Drugs|February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lungSanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.Chemistry & Biology|September 17, 2013
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cellsJared J Barrott, Philip F Hughes, Takuya Osada, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|August 20, 2015
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric LigandsSara Sattin, Jiahui Tao, Gerolamo Vettoretti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphomaQin C Ryan, Donna Headlee, Milin Acharya, et al.Cancer Genetics and Cytogenetics|December 8, 2009
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancerYoufeng Yang, Vladimir A Valera, Hesed M Padilla-Nash, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomasArun Rajan, Ronan J Kelly, Jane B Trepel, et al.Cancer Medicine|October 8, 2022
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxelGuillaume Joe Pegna, Min-Jung Lee, Cody J Peer, et al.Hepatology (Baltimore, Md.)|June 11, 2015
Alternative splicing of the cell fate determinant Numb in hepatocellular carcinomaYinying Lu, Wanping Xu, Junfang Ji, et al.Blood|July 20, 2002
Regulation of leukemic cell adhesion, proliferation, and survival by beta-cateninEun Joo Chung, Sang-Gu Hwang, PhuongMai Nguyen, et al.Pageof 26